Sign in
4

Changes in Ownership

TREACE MEDICAL CONCEPTS, INC. Filed Acc 0001209191-22-057418

SVP, Marketing sold 25,000 shares at $24.27 ($606,680)

  • SVP, Marketing acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scanlan Sean F. · SVP, Marketing

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-14 Exercise or conversion : show line 1 in the form +25,000 $0.10 $2,500 34,975 D
2022-11-14 Sale : show line 2 in the form −25,000 $24.27 $606,680 9,975 D
Open-market sales · 25,000 sh · avg $24.27 · $606,680

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2022-11-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −25,000 $0.10 $2,500 $0.10 2024-12-15 25,000 108,750 D
Loading xslF345X03/doc4.xml…